is a biotechnology company spun-out from the University of California, Los Angeles. The company has developed a series of nanotechnology-enabled rare-cell sorting platforms, the Cytolumina CytoTrapNano™ (also known as NanoVelcro chip in the scientific literature) that can be used to detect and characterize circulating tumor cells (CTCs), paving the way for the implementation of precision medicine in cancer.